Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GRWG GrowGeneration	$1.05	$1.27	$0.91 ▼ $3.38	$62.43M	3.39	712,591 shs	312,829 shs
HIMX Himax Technologies	$7.49 +0.7%	$9.52	$4.80 ▼ $13.91	$1.31B	2.13	1.73 million shs	1.50 million shs
MRNA Moderna	$27.72 +2.1%	$34.43	$26.32 ▼ $170.47	$10.72B	1.86	6.94 million shs	11.79 million shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GRWG GrowGeneration	-2.78%	-11.02%	-7.89%	-37.87%	-63.79%
HIMX Himax Technologies	+1.22%	-10.47%	-26.19%	-7.46%	+37.52%
MRNA Moderna	-4.20%	-19.76%	-12.27%	-34.68%	-74.28%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GRWG GrowGeneration	2.4748 of 5 stars	3.1	1.0	0.0	0.0	3.9	1.7	1.3
HIMX Himax Technologies	3.7699 of 5 stars	3.5	2.0	2.5	0.0	2.7	3.3	1.3
MRNA Moderna	4.353 of 5 stars	4.0	1.0	0.0	4.6	1.9	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GRWG GrowGeneration	2.25	Hold	$2.75	161.90% Upside
HIMX Himax Technologies	3.00	Buy	$15.00	100.27% Upside
MRNA Moderna	2.04	Hold	$59.00	112.84% Upside

Current Analyst Ratings Breakdown

Latest HIMX, GRWG, and MRNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/21/2025	MRNA Moderna	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$40.00 ➝ $33.00
3/13/2025	MRNA Moderna	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$40.00
2/19/2025	MRNA Moderna	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$96.00 ➝ $78.00
2/18/2025	MRNA Moderna	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Sector Perform	$40.00 ➝ $40.00
2/18/2025	MRNA Moderna	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$111.00 ➝ $45.00
2/14/2025	MRNA Moderna	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$45.00
2/14/2025	MRNA Moderna	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$50.00
2/11/2025	MRNA Moderna	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underperform ➝ Underperform	$41.00 ➝ $34.00
1/29/2025	MRNA Moderna	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$99.00 ➝ $51.00
1/28/2025	MRNA Moderna	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$112.00 ➝ $99.00

(Data available from 4/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GRWG GrowGeneration	$188.87M	0.33	N/A	N/A	$2.83 per share	0.37
HIMX Himax Technologies	$906.80M	1.44	$0.39 per share	19.25	$5.13 per share	1.46
MRNA Moderna	$3.20B	3.35	N/A	N/A	$28.33 per share	0.98

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GRWG GrowGeneration	-$46.50M	-$0.82	N/A	N/A	N/A	-26.62%	-23.73%	-17.03%	5/6/2025 (Estimated)
HIMX Himax Technologies	$79.75M	$0.45	16.64	∞	N/A	8.80%	9.09%	4.84%	5/8/2025 (Estimated)
MRNA Moderna	-$3.56B	-$9.28	N/A	N/A	N/A	-110.04%	-28.74%	-21.83%	5/1/2025 (Estimated)

Latest HIMX, GRWG, and MRNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/13/2025	Q4 2024	HIMX Himax Technologies	N/A	$0.14	N/A	$0.14	N/A	$237.22 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GRWG GrowGeneration	N/A	N/A	N/A	N/A	N/A
HIMX Himax Technologies	$0.28	3.74%	+2.16%	62.22%	N/A
MRNA Moderna	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GRWG GrowGeneration	N/A	5.00	3.04
HIMX Himax Technologies	0.03	1.65	1.43
MRNA Moderna	N/A	3.67	3.62

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GRWG GrowGeneration	36.02%
HIMX Himax Technologies	69.81%
MRNA Moderna	75.33%

Insider Ownership

Company	Insider Ownership
GRWG GrowGeneration	7.07%
HIMX Himax Technologies	31.50%
MRNA Moderna	11.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GRWG GrowGeneration	690	59.46 million	55.06 million	Optionable
HIMX Himax Technologies	2,164	174.72 million	119.69 million	Optionable
MRNA Moderna	3,900	386.62 million	324.40 million	Optionable

HIMX, GRWG, and MRNA Headlines

Recent News About These Companies

4MRNA : Moderna Options Trading: A Deep Dive into Market Sentiment

April 2 at 1:51 PM | benzinga.com

Edmond DE Rothschild Holding S.A. Cuts Stake in Moderna, Inc. (NASDAQ:MRNA)

April 2 at 5:33 AM | marketbeat.com

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by AIA Group Ltd

April 2 at 5:24 AM | marketbeat.com

3,940,194 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Norges Bank

April 2 at 4:22 AM | marketbeat.com

Moderna (NASDAQ:MRNA) Sets New 52-Week Low - What's Next?

April 2 at 4:11 AM | marketbeat.com

Is Moderna, Inc. (MRNA) the Best Gene-Editing Stock to Buy?

April 2 at 3:49 AM | msn.com

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

April 1 at 2:01 PM | cnbc.com

Moderna (NASDAQ:MRNA) Shares Gap Down - What's Next?

April 1 at 1:17 PM | marketbeat.com

Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.

April 1 at 8:25 AM | zacks.com

UniSuper Management Pty Ltd Purchases 20,862 Shares of Moderna, Inc. (NASDAQ:MRNA)

April 1 at 4:14 AM | marketbeat.com

Corebridge Financial Inc. Sells 28,775 Shares of Moderna, Inc. (NASDAQ:MRNA)

April 1 at 3:47 AM | marketbeat.com

Watch These Moderna Price Levels as Stock Sinks to 5-Year Low

April 1 at 2:13 AM | msn.com

Study estimates current Moderna vaccine 53% effective against COVID hospitalization

March 31 at 9:12 PM | cidrap.umn.edu

Moderna put volume heavy and directionally bearish

March 31 at 9:12 PM | markets.businessinsider.com

FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade)

March 31 at 9:12 PM | seekingalpha.com

Moderna (MRNA) Stock Trades Down, Here Is Why

March 31 at 9:12 PM | msn.com

S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official

March 31 at 5:01 PM | investopedia.com

Moderna, biotech stocks slide following resignation of FDA official Peter Marks

March 31 at 4:12 PM | msn.com

Top Stock Movers Now: Tesla, Nvidia, Moderna, and More

March 31 at 4:12 PM | msn.com

Moderna, Rocket, Hut 8: Market Minute

March 31 at 4:12 PM | finance.yahoo.com

Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation'

March 31 at 4:12 PM | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Warren Buffett Swaps VOO for This Reliable Dividend Stock
By Sarah Horvath | March 7, 2025
View Warren Buffett Swaps VOO for This Reliable Dividend Stock
NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
By Thomas Hughes | March 12, 2025
View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
By Jeffrey Neal Johnson | March 21, 2025
View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
3 Defense Stocks Set to Benefit From Increased Military Spending
By Chris Markoch | March 20, 2025
View 3 Defense Stocks Set to Benefit From Increased Military Spending
Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares
By Jea Yu | March 11, 2025
View Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

HIMX, GRWG, and MRNA Company Descriptions

GrowGeneration NASDAQ:GRWG

$1.05 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$1.01 -0.04 (-3.33%)

As of 06:40 PM Eastern

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. The company engages in the marketing and distribution of nutrients, additives, growing media, lighting, and environmental control systems, as well as other indoor and outdoor growing products. It operates a chain of stores in California, Colorado, Michigan, Maine, Oklahoma, Oregon, Washington, Montana, New York, Ohio, Mississippi, Missouri, Arizona, Rhode Island, Florida, Massachusetts, Virginia, New Jersey, and New Mexico, as well as growgeneration.com, an online superstore for cultivators, a wholesale business for resellers, HRG Distribution, and benching, racking, and storage solutions and MMI. The company was formerly known as Easylife Corp. GrowGeneration Corp. was founded in 2008 and is based in Greenwood Village, Colorado.

Himax Technologies NASDAQ:HIMX

$7.49 +0.05 (+0.67%)

Closing price 04:00 PM Eastern

Extended Trading

$7.06 -0.43 (-5.67%)

As of 07:59 PM Eastern

Himax Technologies, Inc., a fabless semiconductor company, provides display imaging processing technologies in China, Taiwan, the Philippines, Korea, Japan, Europe, and the United States. The company operates in two segments, Driver IC and Non-Driver Products. It offers display driver integrated circuits (ICs) and timing controllers that are used in televisions, PC monitors, laptops, mobile phones, tablets, automotive, ePaper devices, industrial displays, and other products. The company also provides automotive IC solutions, including traditional driver ICs; advanced in-cell touch and display driver integration; large touch and display driver integration; and local dimming timing controllers, as well as active matrix organic light-emitting diode (AMOLED) solutions, including AMOLED drivers, timing controllers, and touch controller ICs. In addition, it offers application specific IC services; liquid crystal on silicon and micro-electro mechanical system products; Power ICs; complementary metal oxide semiconductor image sensor products; wafer level optics products; 3D sensing products; and ultralow power WiseEye smart image sensing products. The company markets its display drivers to panel manufacturers, mobile device module manufacturers, and manufacturers of end-use products. Himax Technologies, Inc. was incorporated in 2001 and is headquartered in Tainan City, Taiwan.

Moderna NASDAQ:MRNA

$27.72 +0.56 (+2.06%)

Closing price 04:00 PM Eastern

Extended Trading

$26.50 -1.22 (-4.38%)

As of 07:59 PM Eastern

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time